Manulife (Manufacturers Life Insurance)’s Mereo BioPharma MREO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,435
Closed -$57.5K 2961
2024
Q4
$57.5K Buy
16,435
+1,666
+11% +$6.55K ﹤0.01% 2921
2024
Q3
$60.7K Buy
14,769
+148
+1% +$612 ﹤0.01% 2969
2024
Q2
$52.6K Sell
14,621
-104,357
-88% -$338K ﹤0.01% 2942
2024
Q1
$393K Buy
+118,978
New +$403K ﹤0.01% 2292

Other funds holding MREO

Manulife (Manufacturers Life Insurance)'s MREO Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Mereo BioPharma (MREO) in Q1 2025, closing a stake of 16,435 shares — an estimated $57.5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MREO in Q1 2024 and held it in 4 quarters. The position peaked at $393K in Q1 2024. 90 funds tracked by Wall St. Rank hold MREO as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Mereo BioPharma position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 16,435 Mereo BioPharma shares in Q1 2025, an estimated $57.5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Mereo BioPharma in Q1 2024 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Mereo BioPharma position peaked at $393K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.